Priced to Win - How Small Life Science Companies Turn the MFN Drug Pricing Disruption Into a Commercial Advantage episode artwork

EPISODE · Jun 22, 2026 · 28 MIN

Priced to Win - How Small Life Science Companies Turn the MFN Drug Pricing Disruption Into a Commercial Advantage

from Healthcare Logic for Growth · host Eric Marr

The MFN drug pricing framework - what began as voluntary agreements with sixteen of the largest pharmaceutical companies - is now moving toward mandatory rules that will reach smaller biotechs and pharma companies. At the same time, a 100% pharmaceutical tariff takes effect September 29th for smaller manufacturers, with a lower 20% rate available only to companies that have engaged the MFN framework and filed domestic manufacturing plans. BIO International opens at the same time of this published episode, June 22nd. So, in this episode, we flip the script: instead of treating MFN as a threat, we show small life science companies how to turn it into a commercial advantage - with five specific actions you can take starting this week.   Sources Referenced in This Episode: Skadden Arps — "MFN Drug Pricing and Impact on International Life Sciences Licensing Deals" — June 1, 2026 BioTech Briefings / Gibson Dunn — "MFN Drug Pricing in 2026: Voluntary Deals Are Giving Way to Mandatory Rules" — March 2026 Clinical Leader — "U.S. Pharma Tariffs and MFN Become Law After April 2 Update" — April 2026 AJMC — "MFN Drug Pricing Proposal Raises Questions Around Access, Innovation, and Commercial Coverage" — June 2026 BioSpace — "Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026" PharmExec — "What the Most Favored Nation Executive Order Means to Pharma Brands and Future Implications" — April 2026 BIO International Convention 2026 — San Diego, June 22–25, 2026 — convention.bio.org White House Council of Economic Advisers — "Savings from Most-Favored-Nation Drug Pricing Policy" — May 2026 About Life Science Logic: Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve. Visit https://lifesciencelogic.com/ or reach us at [email protected].   Healthcare Logic for Growth  ·  Life Science Logic  ·  [email protected]  ·  © 2026 Life Science Logic

Episode metadata supplied by the publisher feed · Published Jun 22, 2026

Embed this episode

NOW PLAYING

Priced to Win - How Small Life Science Companies Turn the MFN Drug Pricing Disruption Into a Commercial Advantage

0:00 28:07

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Healthcare Logic for Growth?

This episode is 28 minutes long.

When was this Healthcare Logic for Growth episode published?

This episode was published on June 22, 2026.

Can I download this Healthcare Logic for Growth episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!